About GYRE Dividend Returns
Gyre Therapeutics, Inc. (GYRE) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of GYRE over the past year?
Gyre Therapeutics, Inc. (GYRE) delivered a return of -28.97% over the past year. Since GYRE does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in GYRE be worth today?
A $10,000 investment in Gyre Therapeutics, Inc. one year ago would be worth $7,103 today, representing a loss of $2,897.
Q3Does GYRE pay dividends?
Gyre Therapeutics, Inc. (GYRE) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For GYRE, the total return equals the price-only return.
Q4Did GYRE beat the S&P 500?
No, Gyre Therapeutics, Inc. (GYRE) underperformed the S&P 500 by 44.42 percentage points over the past year. GYRE delivered a total return of -28.97%, compared to the S&P 500's 15.45%. This means a passive S&P 500 index fund outperformed GYRE by 44.42pp during this period.
Q5What is GYRE's worst drawdown?
Gyre Therapeutics, Inc. (GYRE) experienced a maximum drawdown of -47.80% over the past year, declining from its peak on 2025-03-17 to its trough on 2025-04-01. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is GYRE's long-term total return over 10, 20, or 30 years?
Gyre Therapeutics, Inc. (GYRE) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is -92.6% (-23.0% CAGR) — $10,000 would have grown to $736. Over 20 years: -93.2% total return (-12.6% CAGR) — $10,000 → $681. Over 30 years: -93.2% total return (-8.6% CAGR) — $10,000 → $681. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was GYRE's best and worst year?
Gyre Therapeutics, Inc.'s best calendar year was 2009 with a total return of 472.6%. Its worst year was 2021 with a total return of -85.2%. This range shows the volatility investors should expect — the difference between the best and worst year is 557.8 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).